Karla Plevová, Ph.D.

Publications that are part of the Web of Science database, possibly also other publications chosen by authors.

2021

• Ntoufa, S; Gerousi, M; Laidou, S; Psomopoulos, F; Tsiolas, G; Moysiadis, T; Papakonstantinou, N; Mansouri, L; Anagnostopoulos, A; Stavrogianni, N; Pospisilova, S; Plevova, K; Makris, AM; Rosenquist, R; Stamatopoulos, K, 2021: RPS15 mutations rewire RNA translation in chronic lymphocytic leukemia. BLOOD ADVANCES 5(13), p. 2788 - 2792, doi: 10.1182/bloodadvances.2020001717
• Taus, P; Pospisilova, S; Plevova, K, 2021: Identification of Clinically Relevant Subgroups of Chronic Lymphocytic Leukemia Through Discovery of Abnormal Molecular Pathways. FRONTIERS IN GENETICS 12, doi: 10.3389/fgene.2021.627964
• Gemenetzi, K; Psomopoulos, F; Carriles, AA; Gounari, M; Minici, C; Plevova, K; Sutton, LA; Tsagiopoulou, M; Baliakas, P; Pasentsis, K; Anagnostopoulos, A; Sandaltzopoulos, R; Rosenquist, R; Davi, F; Pospisilova, S; Ghia, P; Stamatopoulos, K; Degano, M; Chatzidimitriou, A, 2021: Higher-order immunoglobulin repertoire restrictions in CLL: the illustrative case of stereotyped subsets 2 and 169. BLOOD 137(14), p. 1895 - 1904, doi: 10.1182/blood.2020005216
• Leeksma, AC; Baliakas, P; Moysiadis, T; Puiggros, A; Plevova, K; van der Kevie-Kersemaekers, AM; Posthuma, H; Rodriguez-Vicente, AE; Tran, AN; Barbany, G; Mansouri, L; Gunnarsson, R; Parker, H; van den Berg, E; Bellido, M; Davis, Z; Wall, M; Scarpelli, I; Osterborg, A; Hansson, L; Jarosova, M; Ghia, P; Poddighe, P; Espinet, B; Pospisilova, S; Tam, C; Ysebaert, L; Nguyen-Khac, F; Oscier, D; Haferlach, C; Schoumans, J; Stevens-Kroef, M; Eldering, E; Stamatopoulos, K; Rosenquist, R; Strefford, JC; Mellink, C; Kater, AP, 2021: Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multicenter study. HAEMATOLOGICA 106(1), p. 87 - 97, doi: 10.3324/haematol.2019.239947

2020

• Stranska, K; Plevova, K; Francova, HS; Skabrahova, H; Von Jagwitz-Biegnitz, M; Radova, L; Panovska, A; Hrobkova, S; Brychtova, Y; Urbanova, R; Smolej, L; Simkovic, M; Zuchnicka, J; Mohammadova, L; Spacek, M; Mayer, J; Pospisilova, S; Doubek, M, 2020: Profiling of biological and environmental risk factors in immunogenetic subgroups of chronic lymphocytic leukemia - Czech national study. BIOMEDICAL PAPERS-OLOMOUC 164(4), p. 425 - 434, doi: 10.5507/bp.2019.046
• Panovska, A; Nemcova, L; Nekvindova, L; Spacek, M; Simkovic, M; Papajik, T; Brejcha, M; Lysak, D; Zuchnicka, J; Novak, J; Starostka, D; Poul, H; Vrbacky, F; Vodarek, P; Urbanova, R; Plevova, K; Pospisilova, S; Maslejova, S; Brychtova, Y; Koritakova, E; Smolej, L; Doubek, M, 2020: Real-world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil, and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: TheGO-CLLEARStudy by the CzechCLLStudy Group. HEMATOLOGICAL ONCOLOGY 38(4), p. 509 - 516, doi: 10.1002/hon.2744
• Komkov, A; Miroshnichenkova, A; Nugmanov, G; Popov, A; Pogorelyy, M; Zapletalova, E; Jelinkova, H; Pospisilova, S; Lebedev, Y; Chudakov, D; Olshanskaya, Y; Plevova, K; Maschan, M; Mamedov, I, 2020: High-throughput sequencing of T-cell receptor alpha chain clonal rearrangements at the DNA level in lymphoid malignancies. BRITISH JOURNAL OF HAEMATOLOGY 188(5), p. 723 - 731, doi: 10.1111/bjh.16230

2019

• Vaska, A; Makohusova, M; Plevova, K; Skalicka, K; Cermak, M; Chovanec, F; Fabri, O; Svec, P; Kolenova, A, 2019: Clinical impact of genomic analysis in children with B-acute lymphoblastic leukemia: A pilot study in Slovakia. NEOPLASMA 66(6), p. 1009 - 1018, doi: 10.4149/neo_2019_190328N274
• Jarosov?, M; Plevov?, K; Kotaskov?, J; Doubek, M; Posp?silov?, S, 2019: The importance of complex karyotype in prognostication and treatment of chronic lymphocytic leukemia (CLL): a comprehensive review of the literature. LEUKEMIA & LYMPHOMA 60(10), p. 2348 - 2355, doi: 10.1080/10428194.2019.1576038
• Taus, P; Plevova, K; Darzentas, N; Pal, K; Pospisilova, S, 2019: Identification of novel chronic lymphocytic leukemia subtypes using pathway mutation scores and consensus clustering. EUROPEAN JOURNAL OF HUMAN GENETICS 27, p. 1553 - 1554
• Vaska, A; Makohusova, M; Plevova, K; Hikkel, I; Cermak, M; Skalicka, K; Chovanec, F; Fabri, O; Kolenova, A, 2019: Analysis of Genetic Prognostic Markers of Pediatric B-Acute Lymphoblastic Leukemia in Slovak Population. PEDIATRIC BLOOD & CANCER 66, p. S256 - S257
• Baliakas, P; Jeromin, S; Iskas, M; Puiggros, A; Plevova, K; Nguyen-Khac, F; Davis, Z; Rigolin, GM; Visentin, A; Xochelli, A; Delgado, J; Baran-Marszak, F; Stalika, E; Abrisqueta, P; Durechova, K; Papaioannou, G; Eclache, V; Dimou, M; Iliakis, T; Collado, R; Doubek, M; Calasanz, MJ; Ruiz-Xiville, N; Moreno, C; Jarosova, M; Leeksma, AC; Panayiotidis, P; Podgornik, H; Cymbalista, F; Anagnostopoulos, A; Trentin, L; Stavroyianni, N; Davi, F; Ghia, P; Kater, AP; Cuneo, A; Pospisilova, S; Espinet, B; Athanasiadou, A; Oscier, D; Haferlach, C; Stamatopoulos, K, 2019: Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact. BLOOD 133(11), p. 1205 - 1216, doi: 10.1182/blood-2018-09-873083
• Hynst, J; Plevova, K; Radova, L; Bystry, V; Pali, K; Pospisilova, S, 2019: Bioinformatic pipelines for whole transcriptome sequencing data exploitation in leukemia patients with complex structural variants. PEERJ 7, doi: 10.7717/peerj.7071

2018

• Plesingerova, H; Janovska, P; Mishra, A; Smyckova, L; Poppova, L; Libra, A; Plevova, K; Ovesna, P; Radova, L; Doubek, M; Pavlova, S; Pospisilova, S; Bryja, V, 2018: Expression of COBLL1 encoding novel ROR1 binding partner is robust predictor of survival in chronic lymphocytic leukemia. HAEMATOLOGICA 103(2), p. 313 - 324, doi: 10.3324/haematol.2017.178699
• Brazdilova, K; Plevova, K; Francova, HS; Kockova, H; Borsky, M; Bikos, V; Malcikova, J; Oltova, A; Kotaskova, J; Tichy, B; Brychtova, Y; Mayer, J; Doubek, M; Pospisilova, S, 2018: Multiple productive IGH rearrangements denote oligoclonality even in immunophenotypically monoclonal CLL. LEUKEMIA 32(1), p. 234 - 236, doi: 10.1038/leu.2017.274
• Kubesova, B; Pavlova, S; Malcikova, J; Kabathova, J; Radova, L; Tom, N; Tichy, B; Plevova, K; Kantorova, B; Fiedorova, K; Slavikova, M; Bystry, V; Kissova, J; Gisslinger, B; Gisslinger, H; Penka, M; Mayer, J; Kralovics, R; Pospisilova, S; Doubek, M, 2018: Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational status. LEUKEMIA 32(2), p. 450 - 461, doi: 10.1038/leu.2017.230
• Kozubik, KS; Radova, L; Pesova, M; Reblova, K; Trizuljak, J; Plevova, K; Fiamoli, V; Gumulec, J; Urbankova, H; Szotkowski, T; Mayer, J; Pospisilova, S; Doubek, M, 2018: C-terminal RUNX1 mutation in familial platelet disorder with predisposition to myeloid malignancies. INTERNATIONAL JOURNAL OF HEMATOLOGY 108(6), p. 652 - 657, doi: 10.1007/s12185-018-2514-3
• Baliakas, P.; Mattsson, M.; Hadzidimitriou, A.; Minga, E.; Agathangelidis, A.; Sutton, L.; Scarfo, L.; Davis, Z.; Yan, X.; Plevova, K.; Sandberg, Y.; Vojdeman, F. J.; Tzenou, T.; Chu, C. C.; Veronese, S.; Mansouri, L.; Smedby, K. E.; Giudicelli, V.; Nguyen-Khac, F.; Panagiotidis, P.; Juliusson, G.; Anagnostopoulos, A.; Lefranc, M.; Trentin, L.; Catherwood, M.; Montillo, M.; Niemann, C. U.; Langerak, A. W.; Pospisilova, S.; Stavroyianni, N.; Chiorazzi, N.; Oscier, D.; Jelinek, D. F.; Shanafelt, T.; Darzentas, N.; Belessi, C.; Davi, F.; Ghia, P.; Rosenquist, R.; Stamatopoulos, K., 2018: No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy. HAEMATOLOGICA , doi: 10.3324/haematol.2017.182634
• Janovska, P; Verner, J; Kohoutek, J; Bryjova, L; Gregorova, M; Dzimkova, M; Skabrahova, H; Radaszkiewicz, T; Ovesna, P; Blanarova, OV; Nemcova, T; Hoferova, Z; Vasickova, K; Smyckova, L; Egle, A; Pavlova, S; Poppova, L; Plevova, K; Pospisilova, S; Bryja, V, 2018: Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia. BLOOD 131(11), p. 1206 - 1218, doi: 10.1182/blood-2017-05-786947

2017

• Baliakas, P; Jeronim, S; Iskas, M; Puiggros, A; Plevova, K; Xochelli, A; Delgado, J; Kotaskova, J; Stalika, E; Costa, PA; Durechova, K; Papaioannou, G; Collado, R; Doubek, M; Calasanz, MJ; Ruiz-Xiville, N; Moreno, C; Anagnostopoulos, A; Stavroyianni, N; Kater, A; Espinet, B; Pospisilova, S; Athanasiadou, A; Stamatopoulos, K; Haferlach, C, 2017: Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations with other bio-markers and clinical impact. LEUKEMIA & LYMPHOMA 58, p. 65 - 66
• Kotaskova, J; Pavlova, S; Plevova, K; Malcikova, J; Stehlikova, O; Poppova, L; Kockova, H; Doubek, M; Bryja, V; Pospisilova, S, 2017: TREATMENT WITH BCR INHIBITORS INCREASES ROR1 EXPRESSION IN CLL CELLS. HAEMATOLOGICA 102, p. 414 - 414
• Young, E; Noerenberg, D; Mansouri, L; Ljungstrom, V; Frick, M; Sutton, LA; Blakemore, SJ; Galan-Sousa, J; Plevova, K; Baliakas, P; Rossi, D; Clifford, R; Roos-Weil, D; Navrkalova, V; Dorken, B; Schmitt, CA; Smedby, KE; Juliusson, G; Giacopelli, B; Blachly, JS; Belessi, C; Panagiotidis, P; Chiorazzi, N; Davi, F; Langerak, AW; Oscier, D; Schuh, A; Gaidano, G; Ghia, P; Xu, W; Fan, L; Bernard, OA; Nguyen-Khac, F; Rassenti, L; Li, J; Kipps, TJ; Stamatopoulos, K; Pospisilova, S; Zenz, T; Oakes, CC; Strefford, JC; Rosenquist, R; Damm, F, 2017: EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia. LEUKEMIA 31(7), p. 1547 - 1554, doi: 10.1038/leu.2016.359
• Bhoi, S; Mansouri, L; Castellano, G; Sutton, LA; Papakonstantinou, N; Queiros, A; Ek, S; Emruli, VK; Plevova, K; Ntoufa, S; Davis, Z; Young, E; Goransson-Kultima, H; Isaksson, A; Smedby, KE; Gaidano, G; Langerak, AW; Davi, F; Rossi, D; Oscier, D; Pospisilova, S; Ghia, P; Campo, E; Stamatopoulos, K; Martin-Subero, JI; Rosenquist, R, 2017: DNA METHYLATION PROFILING IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS CARRYING STEREOTYPED B-CELL RECEPTORS: A DIFFERENT CELLULAR ORIGIN FOR SUBSET #2?. HAEMATOLOGICA 102, p. 68 - 68
• Baliakas, P; Jeromin, S; Iskas, M; Puiggros, A; Plevova, K; Xochelli, A; Delgado, J; Kotaskova, J; Stalika, E; Abrisqueta, P; Durechova, K; Papaioannou, G; Collado, R; Doubek, M; Calasanz, MJ; Ruiz-Xiville, N; Moreno, C; Leeksma, AC; Anagnostopoulos, A; Ghia, P; Stavroyianni, N; Kater, AP; Espinet, B; Pospisilova, S; Athanasiadou, A; Stamatopoulos, K; Haferlach, C, 2017: CYTOGENETIC COMPLEXITY IN CHRONIC LYMPHOCYTIC LEUKEMIA: DEFINITIONS, ASSOCIATIONS WITH OTHER BIOMARKERS AND CLINICAL IMPACT; A RETROSPECTIVE STUDY ON BEHALF OF ERIC. HAEMATOLOGICA 102, p. 170 - 170
• Plevova, K; Malcikova, J; Pavlova, S; Kotaskova, J; Poppova, L; Smardova, J; Diviskova, E; Durechova, K; Oltova, A; Brychtova, Y; Panovska, A; Doubek, M; Pospisilova, S, 2017: BIALLELIC TP53 GENE MUTATIONS DUE TO COPY-NEUTRAL LOSS OF HETEROZYGOSITY AND MONOALLELIC MUTATIONS IN ABSENCE OF 17P DELETION OCCUR IN CLL WITH COMPARABLE FREQUENCY. HAEMATOLOGICA 102, p. 65 - 66
• Sutton, LA; Cortese, D; Ljungstrom, V; Plevova, K; Rossi, D; Stalika, E; Agathangelidis, A; Scarfo, L; Muggen, AF; Langerak, AW; Pospisilova, S; Davi, F; Ghia, P; Stamatopoulos, K; Brandell, RR, 2017: Transcriptome sequencing provides novel insights into the biology of chronic lymphocytic leukemia: focus on major stereotyped subsets. LEUKEMIA & LYMPHOMA 58, p. 220 - 221
• Plesingerova, H; Librova, Z; Plevova, K; Libra, A; Tichy, B; Francova, HS; Vrbacky, F; Smolej, L; Mayer, J; Bryja, V; Doubek, M; Pospisilova, S, 2017: COBLL1, LPL and ZAP70 expression defines prognostic subgroups of chronic lymphocytic leukemia patients with high accuracy and correlates with IGHV mutational status. LEUKEMIA & LYMPHOMA 58(1), p. 70 - 79, doi: 10.1080/10428194.2016.1180690
• Kantorova, B; Malcikova, J; Brazdilova, K; Borsky, M; Plevova, K; Smardova, J; Radova, L; Tom, N; Trbusek, M; Diviskova, E; Francova, HS; Navrkalova, V; Doubek, M; Brychtova, Y; Mayer, J; Pospisilova, S, 2017: Single cell analysis revealed a coexistence of NOTCH1 and TP53 mutations within the same cancer cells in chronic lymphocytic leukaemia patients. BRITISH JOURNAL OF HAEMATOLOGY 178(6), p. 979 - 982, doi: 10.1111/bjh.14176
• Stoklasova, M; Drevojankova, B; Burdova, A; Sablaturova, I; Strnkova, A; Truhlikova, L; Lencesova, Z; Kucharova, H; Brychtova, Y; Panovska, A; Plevova, K; Oltova, A; Mayer, J; Doubek, M; Pospisilova, S; Rytikova, N; Adamova, D; Zygulova, I; Heinzova, V; Zuchnicka, J; Duras, J; Bodzasova, C; Laska, J; Urbankova, M; Jehlikova, Z; Slezak, P; Macurova, J; Janek, D; Bogoczova, E; Klodova, D; Zetkova, Z; Wrobel, M; Brejcha, M, 2017: Rare recurrent chromosomal abnormalities in CLL detected by conventional cytogenetics stimulated by CpG ODN & IL 2 and FISH. MOLECULAR CYTOGENETICS 10
• Jarosova, M; Hruba, M; Oltova, A; Plevova, K; Kruzova, L; Kriegova, E; Fillerova, R; Koritakova, E; Doubek, M; Lysak, D; Prochazka, V; Mraz, M; Indrak, K; Papajik, T, 2017: Chromosome 6q deletion correlates with poor prognosis and low relative expression of FOXO3 in chronic lymphocytic leukemia patients. AMERICAN JOURNAL OF HEMATOLOGY 92(10), p. E604 - E607, doi: 10.1002/ajh.24852

2016

• Kubesova, B; Pavlova, S; Malcikova, J; Kabathova, J; Radova, L; Tom, N; Tichy, B; Plevova, K; Kantorova, B; Fiedorova, K; Kissova, J; Gisslinger, B; Gisslinger, H; Mayer, J; Kralovics, R; Pospisilova, S; Doubek, M, 2016: Low-Burden TP53 Mutations Occur in Chronic Phase of Myeloproliferative Neoplasms Regardless of Hydroxyurea Administration, Disease Type, and JAK2 Status. BLOOD 128(22)
• Navrkalova, V; Young, E; Baliakas, P; Radova, L; Sutton, LA; Plevova, K; Mansouri, L; Ljungstrom, V; Ntoufa, S; Davis, Z; Juliusson, G; Smedby, KE; Belessi, C; Panagiotidis, P; Touloumenidou, T; Davi, F; Langerak, AW; Ghia, P; Strefford, JC; Oscier, D; Mayer, J; Stamatopoulos, K; Pospisilova, S; Rosenquist, R; Trbusek, M, 2016: ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres. HAEMATOLOGICA 101(9), doi: 10.3324/haematol.2016.142968
• Hernandez-Sanchez, M; Radova, L; Kotaskova, J; Tamborero, D; Rodriguez, AE; Plevova, K; Abaigar, M; Bikos, V; Benito, R; Takacova, S; Quijada, M; Martin, AA; Alcoceba, M; de Coca, AG; Doubek, M; Gonzalez, M; Lopez-Bigas, N; Pospisilova, S; Hernandez-Rivas, JM, 2016: Analysis of Clonal Evolution in Chronic Lymphocytic Leukemia from Inactive to Symptomatic Disease Prior Treatment Using Whole-Exome Sequencing. BLOOD 128(22)
• Poppova, L; Janovska, P; Plevova, K; Radova, L; Plesingerova, H; Borsky, M; Kotaskova, J; Kantorova, B; Hlozkova, M; Figulova, J; Brychtova, Y; Machalova, M; Urik, M; Doubek, M; Kozubik, A; Pospisilova, S; Pavlova, S; Bryja, V, 2016: Decreased WNT3 expression in chronic lymphocytic leukaemia is a hallmark of disease progression and identifies patients with worse prognosis in the subgroup with mutated IGHV. BRITISH JOURNAL OF HAEMATOLOGY 175(5), p. 851 - 859, doi: 10.1111/bjh.14312
• Kotaskova, J; Pavlova, S; Greif, I; Stehlikova, O; Plevova, K; Janovska, P; Brychtova, Y; Doubek, M; Pospisilova, S; Bryja, V, 2016: ROR1-based immunomagnetic protocol allows efficient separation of CLL and healthy B cells. BRITISH JOURNAL OF HAEMATOLOGY 175(2), p. 339 - 342, doi: 10.1111/bjh.13848
• Stoklasova, M; Kucharova, H; Burdova, A; Drevojankova, B; Sablaturova, T; Strnkova, A; Truhlikova, L; Yvona, B; Panovska, A; Plevova, K; Oltova, A; Rytikova, N; Petricova, N; Adamova, D; Heinzova, V; Zygulova, I; Laska, J; Zuchnicka, J; Bodzasova, C; Duras, J; Urbankova, M; Jehlikova, Z; Slezak, P; Macurova, J; Janek, D; Bogoczova, E; Wrobel, M; Klodova, D; Zetkova, Z; Brejcha, M, 2016: RARE RECURRENT CHROMOSOMAL ABNORMALITIES IN CLL DETECTED BY CONVENTIONAL CYTOGENETICS AFTER STIMULATION WITH CPG-ODN & IL-2 AND FISH. HAEMATOLOGICA 101, p. 717 - 717
• Baliakas, P; Mattsson, M; Hadzidimitriou, A; Minga, E; Agathangelidis, A; Sutton, LA; Scarfo, L; Davis, Z; Yan, XJ; Plevova, K; Sandberg, Y; Vojdeman, FJ; Tzenou, T; Chu, CC; Veroneze, S; Mansouri, L; Smedby, KE; Giudicelli, V; Nguyen-Khac, F; Panagiotidis, P; Juliusson, G; Anagnostopoulos, A; Lefranc, MP; Trentin, L; Catherwood, M; Montillo, M; Niemann, CU; Langerak, AW; Pospisilova, S; Stavroyianni, N; Chiorazzi, N; Oscier, D; Jelinek, DF; Shanafelt, T; Darzentas, N; Belessi, C; Davi, F; Ghia, P; Rosenquist, R; Stamatopoulos, K, 2016: NO IMPROVEMENT IN LONG-TERM OVERALL SURVIVAL AFTER THE INTRODUCTION OF CHEMO(IMMUNO)THERAPY FOR CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS BELONGING TO STEREOTYPED SUBSET #2. HAEMATOLOGICA 101, p. 231 - 231
• Turchaninova, MA; Davydov, A; Britanova, OV; Shugay, M; Bikos, V; Egorov, ES; Kirgizova, VI; Merzlyak, EM; Staroverov, DB; Bolotin, DA; Mamedov, IZ; Izraelson, M; Logacheva, MD; Kladova, O; Plevova, K; Pospisilova, S; Chudakov, DM, 2016: High-quality full-length immunoglobulin profiling with unique molecular barcoding. NATURE PROTOCOLS 11(9), p. 1599 - 1616, doi: 10.1038/nprot.2016.093
• Kopparapu, PK; Bhoi, S; Mansouri, L; Arabanian, LS; Plevova, K; Pospisilova, S; Wasik, AM; Croci, GA; Sander, B; Paulli, M; Rosenquist, R; Kanduri, M, 2016: Epigenetic silencing of miR-26A1 in chronic lymphocytic leukemia and mantle cell lymphoma: Impact on EZH2 expression. EPIGENETICS 11(5), p. 335 - 343, doi: 10.1080/15592294.2016.1164375
• Sutton, LA; Young, E; Baliakas, P; Hadzidimitriou, A; Moysiadis, T; Plevova, K; Rossi, D; Kminkova, J; Stalika, E; Pedersen, LB; Malcikova, J; Agathangelidis, A; Davis, Z; Mansouri, L; Scarfo, L; Boudjoghra, M; Navarro, A; Muggen, AF; Yan, XJ; Nguyen-Khac, F; Larrayoz, M; Panagiotidis, P; Chiorazzi, N; Niemann, CU; Belessi, C; Campo, E; Strefford, JC; Langerak, AW; Oscier, D; Gaidano, G; Pospisilova, S; Davi, F; Ghia, P; Stamatopoulos, K; Rosenquist, R, 2016: Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors. HAEMATOLOGICA 101(8), p. 959 - 967, doi: 10.3324/haematol.2016.141812
• Poppova, L; Janovska, P; Plevova, K; Radova, L; Plesingerova, H; Borsky, M; Kotaskova, J; Kantorova, B; Hlozkova, M; Figulova, J; Brychtova, Y; Doubek, M; Kozubik, A; Pospisilova, S; Pavlova, S; Bryja, V, 2016: DECREASED EXPRESSION OF WNT3, A CANONICAL WNT PATHWAY LIGAND, IS FREQUENT IN CHRONIC LYMPHOCYTIC LEUKEMIA PROGRESSION AND IDENTIFIES PATIENTS WITH SHORT TREATMENT-FREE SURVIVAL IN MUTATED IGHV SUBSET. HAEMATOLOGICA 101, p. 423 - 424
• Janovska, P; Poppova, L; Plevova, K; Plesingerova, H; Behal, M; Kaucka, M; Ovesna, P; Hlozkova, M; Borsky, M; Stehlikova, O; Brychtova, Y; Doubek, M; Machalova, M; Baskar, S; Kozubik, A; Pospisilova, S; Pavlova, S; Bryja, V, 2016: Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic Leukemia. CLINICAL CANCER RESEARCH 22(2), p. 459 - 469, doi: 10.1158/1078-0432.CCR-15-0154

2015

• Tom, N; Malcikova, J; Radova, L; Kantorova, B; Pardy, F; Pavlova, S; Pal, K; Mraz, M; Tichy, B; Doubek, M; Brychtova, Y; Plevova, K; Mayer, J; Trbusek, M; Pospisilova, S, 2015: MUTATIONS IN THE TP53 GENE SHOW FEATURES OF SOMATIC HYPERMUTATION PROCESS WITH PROMINENT DIFFERENCE BETWEEN IGHV MUTATED AND UNMUTATED CHRONIC LYMPHOCYTIC LEUKEMIA. HAEMATOLOGICA 100, p. 224 - 225
• Baliakas, P; Hadzidimitriou, A; Mattsson, M; Xochelli, A; Sutton, LA; Minga, E; Scarfo, L; Rossi, D; Davis, Z; Agathangelidis, A; Villamor, N; Parker, H; Kotaskova, J; Stalika, E; Plevova, K; Mansouri, L; Cortese, D; Lopez, AN; Delgado, J; Larrayoz, M; Anagnostopoulos, A; Belessi, C; Smedby, KE; Juliusson, G; Strefford, JC; Pospisilova, S; Oscier, D; Gaidano, G; Campo, E; Ghia, P; Rosenquist, R; Stamatopoulos, K, 2015: REFINING PROGNOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH SOMATICALLY HYPERMUTATED B-CELL RECEPTORS: A NOVEL PROGNOSTIC INDEX ON BEHALF OF THE EUROPEAN RESEARCH INITIATIVE ON CLL (ERIC). HAEMATOLOGICA 100, p. 52 - 52
• Plesingerova, H; Janovska, P; Poppova, L; Shaik, A; Jurcickova, Z; Libra, A; Plevova, K; Machac, J; Slapak, I; Pavlova, S; Ovesna, P; Kotaskova, J; Doubek, M; Pospisilova, S; Bryja, V, 2015: UPREGULATED COBLL1 IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) PATIENTS WITH UNMUTATED IGHV IDENTIFIES A COHORT WITH INFERIOR PROGNOSIS. HAEMATOLOGICA 100, p. 50 - 50
• Agathangelidis, A; Bystry, V; Hadzidimitriou, A; Sutton, LA; Minga, E; Kienle, D; Davis, Z; Yan, XJ; Shanafelt, T; Boudjogra, M; Plevova, K; Gounari, M; Xochelli, A; Navarro, A; Chatzouli, M; Pedersen, LB; Baliakas, P; Scarfo, L; Rossi, D; Veronese, S; Facco, M; Bikos, V; Karan-Djurasevic, T; Pavlovic, S; Mansouri, L; Poiron, C; Chu, CC; Stalika, E; Giudicelli, V; Panagiotidis, P; Sudarikov, A; Anagnostopoulos, A; Trentin, L; Catherwood, M; Montillo, M; Gaidano, G; Campo, E; Geisler, CH; Langerak, AW; Pospisilova, S; Lefranc, MP; Chiorazzi, N; Oscier, D; Jelinek, DF; Stilgenbauer, S; Belessi, C; Davi, F; Rosenquist, R; Ghia, P; Darzentas, N; Stamatopoulos, K, 2015: HIGHER-ORDER IMMUNOGLOBULIN SEQUENCE RELATIONS FOR MAJOR SUBSETS OF CHRONIC LYMPHOCYTIC LEUKEMIA: UNIQUENESS VERSUS EQUIVALENCE. HAEMATOLOGICA 100, p. 47 - 48
• Trizuljak, J; Srovnal, J; Plevova, K; Brychtova, Y; Semerad, L; Bakesova, D; Letalova, E; Benedikova, A; Mayer, J; Hajduch, M; Pospisilova, S; Doubek, M, 2015: Analysis of Prognostic Significance of Merkel Cell Polyomavirus in Chronic Lymphocytic Leukemia. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 15(7), p. 439 - 442, doi: 10.1016/j.clml.2015.02.003
• Kantorova, B; Malcikova, J; Smardova, J; Pavlova, S; Trbusek, M; Tom, N; Plevova, K; Tichy, B; Truong, S; Diviskova, E; Kotaskova, J; Oltova, A; Patten, N; Brychtova, Y; Doubek, M; Mayer, J; Pospisilova, S, 2015: TP53 mutation analysis in chronic lymphocytic leukemia: comparison of different detection methods. TUMOR BIOLOGY 36(5), p. 3371 - 3380, doi: 10.1007/s13277-014-2971-0
• Mansouri, L; Sutton, LA; Ljungstrom, V; Bondza, S; Arngarden, L; Bhoi, S; Larsson, J; Cortese, D; Kalushkova, A; Plevova, K; Young, E; Gunnarsson, R; Falk-Sorqvist, E; Lonn, P; Muggen, AF; Yan, XJ; Sander, B; Enblad, G; Smedby, KE; Juliusson, G; Belessi, C; Rung, J; Chiorazzi, N; Strefford, JC; Langerak, AW; Pospisilova, S; Davi, F; Hellstrom, M; Jernberg-Wiklund, H; Ghia, P; Soderberg, O; Stamatopoulos, K; Nilsson, M; Rosenquist, R, 2015: Functional loss of I kappa B epsilon leads to NF-kappa B deregulation in aggressive chronic lymphocytic leukemia. JOURNAL OF EXPERIMENTAL MEDICINE 212(6), p. 833 - 843, doi: 10.1084/jem.20142009
• Ljungstrom, V; Cortese, D; Young, E; Pandzic, T; Mansouri, L; Plevova, K; Sutton, LA; Stavroyianni, N; Agathangelidis, A; Rossi, D; Hoglund, M; Oscier, D; Gaidano, G; Davi, F; Pott, C; Trentin, L; Pospisilova, S; Ghia, P; Stamatopoulos, K; Sjoblom, T; Rosenquist, R, 2015: DISSECTING RESISTANCE MECHANISMS IN CHRONIC LYMPHOCYTIC LEUKEMIA USING WHOLE-EXOME SEQUENCING: IMPACT OF RECURRENT RPS15 MUTATIONS ON P53 DYSREGULATION. HAEMATOLOGICA 100, p. 10 - 11
• Noerenberg, D; Young, E; Ljungstrom, V; Mansouri, L; Plevova, K; Baliakas, P; Blakemore, S; Rossi, D; Clifford, R; Navrkalova, V; Sutton, LA; Smedby, KE; Juliusson, G; Belessi, C; Panagiotidis, P; Chiorazzi, N; Davi, F; Langerak, AW; Schuh, A; Gaidano, G; Strefford, JC; Ghia, P; Stamatopoulos, K; Pospisilova, S; Zenz, T; Rosenquist, R; Damm, F, 2015: EGR2 Mutations in Chronic Lymphocytic Leukemia: A New Bad Player. BLOOD 126(23)
• Kantorova, B; Malcikova, J; Brazdilova, K; Borsky, M; Plevova, K; Smardova, J; Trbusek, M; Brychtova, Y; Doubek, M; Mayer, J; Pospisilova, S, 2015: Single Cell Analysis Proves the Coexistence of NOTCH1 and TP53 Mutations within the Same Cancer Cells in Patients with Chronic Lymphocytic Leukemia. BLOOD 126(23)
• Brazdilova, K; Plevova, K; Francova, HS; Kockova, H; Chmelikova, M; Borsky, M; Burckova, K; Kantorova, B; Tichy, B; Skabrahova, H; Brychtova, Y; Mayer, J; Doubek, M; Pospisilova, S, 2015: Single Cell Analysis of IG Genes in CLL: Cases with Multiple IGH Rearrangements Are Constituted of Several Independent Clones Even When Indistinguishable By Flow Cytometry. BLOOD 126(23)
• Navrkalova, V; Young, E; Baliakas, P; Radova, L; Plevova, K; Sutton, LA; Mansouri, L; Ljungstrom, V; Ntoufa, S; Davis, Z; Juliusson, G; Smedby, KE; Belessi, C; Panagiotidis, P; Davi, F; Langerak, AW; Ghia, P; Strefford, JC; Oscier, DG; Stamatopoulos, K; Pospisilova, S; Rosenquist, R; Trbusek, M, 2015: ATM Mutations in Major Stereotyped CLL Subsets: Enrichment in Subset #2 is Associated with Unfavourable Outcome. BLOOD 126(23)
• Baliakas, P; Puiggros, A; Xochelli, A; Sutton, LA; Nguyen-Khac, F; Gardiner, A; Plevova, K; Ortega, M; Collado, R; Gonzalez, T; Granada, I; Luno, E; Kotaskova, J; Davis, Z; Anagnostopoulos, A; Strefford, J; Pospisilova, S; Davi, F; Athanasiadou, A; Rosenquist, R; Oscier, D; Sola, BE; Stamatopoulos, K, 2015: ADDITIONAL TRISOMIES AMONGST PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA CARRYING TRISOMY 12: THE PARTNER CHROMOSOME MAKES A DIFFERENCE. HAEMATOLOGICA 100, p. 224 - 224
• Young, E; Norenberg, D; Ljungstrom, V; Mansouri, L; Plevova, K; Baliakas, P; Rossi, D; Navrkalova, V; Sutton, LA; Smedby, KE; Juliusson, G; Belessi, C; Panagiotidis, P; Chiorazzi, N; Davi, F; Langerak, AW; Gaidano, G; Ghia, P; Stamatopoulos, K; Pospisilova, S; Zenz, T; Rosenquist, R; Damm, F, 2015: EGR2 mutations in chronic lymphocytic leukemia- a new bad player?. LEUKEMIA & LYMPHOMA 56, p. 83 - 85
• Janovska, P; Poppova, L; Plesingerova, H; Plevova, K; Pavlova, S; Bryja, V, 2015: Wnt/planar cell polarity (PCP) and B cell receptor signaling in chronic lymphocytic leukemia. LEUKEMIA & LYMPHOMA 56, p. 63 - 64
• Kotaskova, J; Malcikova, J; Diviskova, E; Pavlova, S; Mejstrikova, S; Vranova, V; Plevova, K; Plesingerova, H; Doubek, M; Mayer, J; Pospisilova, S, 2015: 13Q DELETION IS PREDOMINANT CYTOGENETIC ABERRATION NEWLY AQUIRED DURING CHRONIC LYMPHOCYTIC LEUKEMIA COURSE IRRESPECTIVE OF DISEASE ACTIVITY AND TREATMENT STATUS. HAEMATOLOGICA 100, p. 417 - 418
• Baliakas, P; Agathangelidis, A; Hadzidimitriou, A; Sutton, LA; Minga, E; Tsanousa, A; Scarfo, L; Davis, Z; Yan, XJ; Shanafelt, T; Plevova, K; Sandberg, Y; Vojdeman, FJ; Boudjogra, M; Tzenou, T; Chatzouli, M; Chu, CC; Veronese, S; Gardiner, A; Mansouri, L; Smedby, KE; Pedersen, LB; Moreno, D; Van Lom, K; Giudicelli, V; Francova, HS; Nguyen-Khac, F; Panagiotidis, P; Juliusson, G; Angelis, L; Anagnostopoulos, A; Lefranc, MP; Facco, M; Trentin, L; Catherwood, M; Montillo, M; Geisler, CH; Langerak, AW; Pospisilova, S; Chiorazzi, N; Oscier, D; Jelinek, DF; Darzentas, N; Belessi, C; Davi, F; Ghia, P; Rosenquist, R; Stamatopoulos, K, 2015: Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations. BLOOD 125(5), p. 856 - 859, doi: 10.1182/blood-2014-09-600874
• Malcikova, J; Stano-Kozubik, K; Tichy, B; Kantorova, B; Pavlova, S; Tom, N; Radova, L; Smardova, J; Pardy, F; Doubek, M; Brychtova, Y; Mraz, M; Plevova, K; Diviskova, E; Oltova, A; Mayer, J; Pospisilova, S; Trbusek, M, 2015: Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia. LEUKEMIA 29(4), p. 877 - 885, doi: 10.1038/leu.2014.297

2014

• Shugay, M; Britanova, OV; Merzlyak, EM; Turchaninova, MA; Mamedov, IZ; Tuganbaev, TR; Bolotin, DA; Staroverov, DB; Putintseva, EV; Plevova, K; Linnemann, C; Shagin, D; Pospisilova, S; Lukyanov, S; Schumacher, TN; Chudakov, DM, 2014: Towards error-free profiling of immune repertoires. NATURE METHODS 11(6), p. 653 - +, doi: 10.1038/NMETH.2960
• Baliakas, P; Hadzidimitriou, A; Sutton, LA; Minga, E; Agathangelidis, A; Nichelatti, M; Tsanousa, A; Scarfo, L; Davis, Z; Yan, XJ; Shanafelt, T; Plevova, K; Sandberg, Y; Vojdeman, FJ; Boudjogra, M; Tzenou, T; Chatzouli, M; Chu, CC; Veronese, S; Gardiner, A; Mansouri, L; Smedby, KE; Pedersen, LB; Van Lom, K; Giudicelli, V; Francova, HS; Nguyen-Khac, F; Panagiotidis, P; Juliusson, G; Angelis, L; Anagnostopoulos, A; Lefranc, MP; Facco, M; Trentin, L; Catherwood, M; Montillo, M; Geisler, CH; Langerak, AW; Pospisilova, S; Chiorazzi, N; Oscier, D; Jelinek, DF; Darzentas, N; Belessi, C; Davi, F; Rosenquist, R; Ghia, P; Stamatopoulos, K, 2014: Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study. LANCET HAEMATOLOGY 1(2), p. E74 - E84
• Xochelli, A; Kavakiotis, I; Agathangelidis, A; Kienle, D; Davis, Z; Yan, XJ; Shanafelt, T; Boudjogra, M; Plevova, K; Chatzouli, M; Pedersen, LB; Veronese, S; Facco, M; Moreno, D; Chu, CC; Giudicelli, V; Panagiotidis, P; Vlahavas, I; Anagnostopoulos, A; Maglaveras, N; Trentin, L; Catherwood, M; Montillo, M; Geisler, CH; Langerak, AW; Pospisilova, S; Lefranc, MP; Chiorazzi, N; Oscier, D; Jelinek, DF; Stilgenbauer, S; Belessi, C; Ghia, P; Davi, F; Rosenquist, R; Darzentas, N; Chouvarda, I; Sutton, LA; Hadzidimitriou, A; Stamatopoulos, K, 2014: Charting Unique Signatures of Somatic Hypermutation Amongst Chronic Lymphocytic Leukemia Patients Expressing IGHV4-34 Clonotypic B Cell Receptors. BLOOD 124(21)
• Baliakas, P; Hadzidimitriou, A; Sutton, LA; Minga, E; Agathangelidis, A; Tsanousa, A; Scarfo, L; Davis, Z; Yan, J; Shanafelt, TD; Plevova, K; Sandberg, Y; Vojdeman, FJ; Boudjoghra, M; Tzenou, T; Chatzouli, M; Chu, CC; Veronese, S; Gardiner, AC; Mansouri, L; Smedby, KE; Pedersen, L; Moreno, D; van Lom, K; Giudicelli, V; Francova, H; Nguyen-Khac, F; Panagiotidis, P; Juliusson, G; Angelis, L; Anagnostopoulos, A; Lefranc, MP; Facco, M; Trentin, L; Catherwood, M; Montillo, M; Geisler, CH; Langerak, AW; Pospisilova, S; Chiorazzi, N; Oscier, D; Jelinek, DF; Darzentas, N; Belessi, C; Davi, F; Rosenquist, R; Ghia, P; Stamatopoulos, K, 2014: Clinical Impact of Stereotyped Antigen Receptors in Chronic Lymphocytic Leukemia. BLOOD 124(21)

• Pokročilé sekvenační metody pro analýzu strukturních přestaveb nádorového genomu, , 2021 - 2024
• Fostering Palliative Care of Adults and Children with Cancer through Advanced Patient Reported Outcome Systems, Evropská unie, 2019 - 2022
• Vývoj modulární bioinformatické platformy pro analýzu dat získaných sekvenováním nové generace, , 2019 - 2021
• Expression and function of activation-induced cytidine deaminase splice variants in normal B cell physiology and chronic lymphocytic leukemia (3SGA5792), Jihomoravský kraj, 2013 - 2016
• Functional and structural changes of microRNAs in lymphoproliferative malignancies and their impact on prognosis and prediction of therapy response (NT11218), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2010 - 2015
• NGS-PTL - Next Generation Sequencing platform for targeted Personalized Therapy of Leukemia (306242), Evropská unie, 2012 - 2015
• SuPReMMe - Podpora profesního růstu a mezinárodní integrace výzkumných týmů v oblasti molekulární medicíny (CZ.1.07/2.3.00/20.0045), Ministerstvo školství, mládeže a tělovýchovy ČR, 2011 - 2014
• Real-time PCR soupravy pro diagnostiku v onkologii (FR-TI2/254), Ministerstvo průmyslu a obchodu ČR, 2010 - 2013
• Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies (MSM0021622430), Ministerstvo školství, mládeže a tělovýchovy ČR, 2007 - 2013
• Involvement of nuclear HMGB proteins in sensitizing of human cells to anticancer drugs inhibiting DNA topoizomerases (GAP301/10/0590), Czech Science Foundation - Standard Grants, 2010 - 2012
• Analysis of changes in genome and its expression in chronic lymphocytic leukemia patients during the disease development (NS10439), Ministry of Health - Departmental Programme of Research and Development (2008-2011), 2009 - 2011